Registry to provide contemporary information regarding characteristics, management and outcomes of outpatients with stable coronary artery disease Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Phase I study of S 78454 in combination with a fixed dose infusion of cisplatin in patients with advanced solid tumours Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Clinical acceptability of trimetazidine 80 mg once daily compared to trimetazidine 35 mg twice daily in patients with chronic stable angina pectoris Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Evaluation of efficacy and clinical benefit of agomelatine in patients with major depressive disorder compared to serotonin-norepinephrine reuptake inhibitor (SNRI) Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Long-term effects of strontium ranelate on knee osteoarthritis symptoms: a two year prospective, randomised, placebo-controlled study Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A study to determine the maintenance of efficacy of agomelatine to prevent relapse in out-patients with major depressive disorder. A 8 to 10 weeks open period treatment with agomelatine followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period Not provided at time of registration and not expected to be available in the future

• Pays Australia, Finland, France, South Africa, United Kingdom
• Organes Aucun
• Spécialités Aucune

Efficacy and safety of agomelatine given orally compared to placebo, in addition to a mood stabiliser in bipolar I patients with a current major depressive episode. An eight week randomised, double-blind, controlled, parallel group study followed by a double-blind extension treatment period up to one year Not provided at time of registration and not expected to be available in the future

• Pays France
• Organes Aucun
• Spécialités Aucune

Effect of agomelatine on cerebral activity measured by functional magnetic resonance imaging (MRI) in patients with major depressive disorder in comparison to healthy volunteers Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Phase I dose-escalation study of S 49076 in patients with advanced solid tumours Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Effect of trimetazidine MR 35 mg on the emergence of choroidal neovascularisation in age-related macular degeneration Not provided at time of registration and not expected to be available in the future

• Pays Aucun
• Organes Aucun
• Spécialités Aucune